A novel methodology for general and chemoselective preparation of non-symmetric 1,3,4-oxadiazoles is developed. This unusual reaction proceeds via polyphosphoric acid-assisted activation of nitroalkanes towards nucleophilic attack with acylhydrazides.
Introduction
Bioisosteric to carboxylate and carboxamide functionalities, 1,3,4-oxadiazoles are oen considered among other privileged heterocyclic scaffolds for drug discovery.
1 Molecules possessing these key structural fragments have demonstrated a wide variety of important biological properties, including antibacterial, antimycobacterial, antifungal, insecticidal, herbicidal, anti-inammatory, analgesic, anticonvulsant and anticancer activities.
2 Several medicinal agents featuring this heterocyclic ring have been marketed, including anti-HIV drug Raltegravir, antihypertensive Nesapidil, and anti-cancer agent Zibotentan (Fig. 1 ). This heterocyclic building block was also used for the construction of chiral catalysts 3 and metal-selective chemosensors. 4 A symmetrically substituted version of this system (5) can be easily obtained by cyclo-condensation of hydrazine hydrate with a variety of carbonyl compounds. 5 Assembly of 1,3,4-oxazoles 4 with two different substituents is much more challenging, as it involves the selective reaction of hydrazine with two different carbonyl compounds, or their synthetic equivalents, to obtain non-symmetric N,N 0 -diacylhydrazide precursor 2 (Scheme 1). Such processes, especially when carried out in one-pot fashion, can be signicantly complicated by side reactions involving trans-acylation of N,N 0 -diacylhydrazide intermediates with excess of the second carbonyl compound and leading to the formation of a mixture of nonsymmetric (4) and symmetric (5) products. A variety of methods were suggested in an attempt to address this issue, most of which are dealing with the moderation of the reactivity of the acylating reagent. 6 In addition, different schemes involving cyclo-condensations of N 0 -alkylidene acylhydrazides, 7 or re-cyclizations of tetrazoles, 8 were also suggested. Herein we wish to report a new preparative method for selective assembly of non-symmetrically substituted 1,3,4-oxadiazoles employing nitroalkanes electrophilicity activated in the presence of polyphosphoric acid that serves as an acylating agent equivalent.
Results and discussion
For several years our group had a great interest in the development of novel acid-mediated cascade transformations of nitroalkenes and nitroalkanes targeting material science and medicinal chemistry applications. It was demonstrated that Fig. 1 1,3 ,4-Oxazoles in drug discovery and medicinal chemistry. nitroalkanes 6 dissolved in polyphosphoric acid (PPA) transform into phosphorylated nitronate 7 showing strong electrophilic properties. This unusual species can be used to design one-pot multi-step transformations involving various carbon-based nucleophiles.
9 The utilization of nucleophilic amines was also demonstrated.
10 Mechanistically, the latter process is related to the classical Nef reaction, 11 employing aniline species 8 instead of water. This reaction provides imidinium ion 9, that can be further employed as a convenient building block for the synthesis of heterocyclic compounds: oxazoles 10, imidazoles 11, and diazines 12-13 (Scheme 2).
10
We wondered about the possibility of employing acylhydrazides 1 as nucleophilic components en route to the 1,3,4-oxazoles scaffolds. Indeed, such a nucleophilic attack to nitronate species 7 would afford (2-acylhydrazineyl)alkaniminium species 14, 12 that should be well suited for an intramolecular 5-exo-trig cyclization involving the carbonyl group of the hydrazide function and providing 4, 5-dihydro-1,3,4-oxadiazol-3-ium of nitroethane) the process proceeded to completion affording mixtures of 10% of non-symmetric product 4aa and 55% symmetric oxadiazole 5a (entry 3). The rest of the starting material polymerized forming highly polar resins. Employment of nitroethane (6a) in excess (3.00 equiv.) did not notably improve the reaction outcome (entries 4 and 5). Evidently, the symmetric product (5a) was formed via acid-mediated transacylation of 1a to produce intermediate symmetric
. In order to suppress this undesired process, we decided to add starting hydrazide 1a in small portions over an extended period of time. This resulted in only marginal improvement, however, in the reactions carried out in the presence of stoichiometric amount of nitroethane (entry 6). Gradual increase of the concentration of nitroethane (entries 7-10) resulted in both the conversion and chemoselectivity of the process to achieve exclusive formation of product 5a at 99% yield (entry 10). We also tested the possibility of employing Eaton's reagent (P 2 O 5 in MeSO 3 H) as a mixture that is oen used as an alternative to PPA in synthesis, but in this medium hydrazide 6a underwent complete hydrolysis to afford benzoic acid as the only detectible product of the reaction (entries 11 and 12) . With the optimized reaction conditions in hand we carried out the reaction between 1a and 6a in preparative scale (1.00 mmol). We were pleased to nd, that oxadiazole 4aa was obtained in this reaction as sole product and isolated in high yield (Scheme 3, entry 1). Hydrazides 1b-g, derived from other aryl-and hetarylcarboxylic acids, also reacted with nitroethane (6a) smoothly, affording the corresponding heterocyclic products (entries 2-7). Remarkably, nonprotected phenols 1e and 1f also reacted uneventfully, which showcases the dual role of polyphosphoric acid as a versatile reaction medium with acidic properties and as a reagent for the reversible installation of temporary protecting phosphatyl groups.
Thorough analysis of literature revealed that synthetic access to monosubstituted oxadiazoles is especially challenging, since preparation of non-symmetric bis-hydrazides 2 required for this cyclo-condensation is severely complicated by relatively high strength formic acid and elevated electrophilicity of formohydrazide derivatives.
13 This problem can be typically circumvented by usage of orthoformates as acylating agents.
14 We felt, however, that in our featured methodology, there should not be a dramatic difference between reactivity of nitroethane (6a) and nitromethane (6b). This would allow for the development of a very general synthetic protocol to access 1,3,4-oxadiazoles with different substitution patterns. To test this possibility, we carried out reactions with a series of benzohydrazides (1a-g) in the presence of excess nitromethane (6b) at 100 C (boiling point of nitromethane). Gratifyingly, these reactions proceeded smoothly affording the corresponding 2-aryl-1,3,4-oxadiazoles 4ab-4gb in high yields (Scheme 3, entries 8-14). Along the same lines, we tested the possibility of employing (2-nitroethyl)benzenes (6c-d) as electrophilic components in the featured transformation. These reactions were more sluggish, probably due to excessive steric hindrance in the phosphorylated nitronate intermediates 7. It was found, however, that the cyclo-condensation could be pushed to complete conversion at 140 C to afford the corresponding 5-benzyloxadiazoles 4ac, 4ad, and 4cd albeit in somewhat lower yields (entries 15-17).
Another major challenge in chemistry of 1,3,4-oxadiazoles is associated with incorporation of ester substituents at C-2 of this heterocyclic scaffold.
15 To address this issue we attempted the reaction of various benzohydrazides (1a,b,e) with ethyl 2-nitroacetate. We were pleased to discover that this reaction also proceeded smoothly under standard reaction conditions (temperature was raised to 130 C to ensure complete conversion) affording the corresponding 1,3,4-oxadiazole-2-carboxylates as the sole isolable product (Scheme 3, entries 18-20). The formation and structural identity of compounds 5a, 4ga, and 4ca was unambiguously conrmed by a single crystal X-ray crystallography (Fig. 2) .
Conclusion
In conclusion, the novel one-pot multistep reaction sequence involving cyclo-condensation of acylhydrazides with electrophilicity-activated nitroalkanes was investigated. Careful optimization of the reaction conditions resulted in excellent chemo-selectivity of this newly developed synthetic protocol towards monosubstituted and non-symmetrically disubstituted 1,3,4-oxadiazoles. High yields of the resulting heterocyclic products and great functional group compatibility of this synthetic methodology was demonstrated.
Experimental part
General information 1 H and 13 C NMR spectra were recorded on a Bruker Avance-III spectrometer (400 or 100 MHz, respectively) equipped with a BBO probe in CDCl 3 or DMSO-d 6 , using TMS as an internal standard. High-resolution mass spectra were registered with a Bruker Maxis spectrometer (electrospray ionization, in MeCN solution, using HCO 2 Na-HCO 2 H for calibration). Melting points were measured with a Stuart smp30 apparatus. All reactions were performed in oven-dried 5 mL round-bottomed asks open to the atmosphere, employing overhead stirring. The reaction progress and purity of isolated compounds were controlled by TLC on Silufol UV-254 plates, with EtOAc as eluent. PPA was obtained by dissolving of P 2 O 5 in 85% orthophosphoric acid according to the published protocol.
16 All reagents and solvents were purchased from commercial vendors and used as received. Physical and spectral properties of compound 5a were identical to those reported in literature. 17 2-Methyl-5-phenyl-1,3,4-oxadiazole (4aa V210). Typical procedure. A 10 mL Erlenmeyer ask equipped with magnetic bar and reux condenser was charged with polyphosphoric acid (86% P 2 O 5 , 1.5 g) and nitroethane (6a) (500 mL, 525 mg, 7.00 mmol) and heated while stirring at 105-115 C. Benzohydrazide (1a) (136 mg, 1.00 mmol) was added slowly in small portions over 1 h, and the mixture was heated for an additional 30 min, when TLC analysis showed the completion of the reaction. The mixture was diluted with water (5 mL), neutralized with 25% aqueous ammonia (4.5-5.0 mL is typically required), and extracted with EtOAc (4 Â 5 mL 3, 164.0, 134.6, 132.5, 131.7, 127.7, 125.5, 121.7, 11.3 ) 3156, 3020, 2947, 1611, 1589, 1494, 1377, 1289, 1234, 1164, 1120, 1073, 933, 853 4, 162.7, 138.1, 133.9, 131.9, 131.3, 127.7, 121.9, 11.3; IR (KBr, lm, cm À1 ) 3104, 3086, 3009, 2936 , 1589 , 1564 , 1454 , 1417 , 1270 , 1241 , 1106 , 1018 ; HRMS (ESI TOF) calculated for C 9 H 6 Cl 2 -N 2 NaO (M + Na) + 250.9749, found 250.9747 (0.8 ppm). 3, . This material was obtained from benzohydrazide (1a) (136 mg, 1.00 mmol) and nitromethane (6b) (581 mL, 610 mg, 10.0 mmol). The reaction was carried out at 95-105 C, and the titled compound was isolated as a colorless oil, R f 0.24 (EtOAc/petroleum ether, 1 : 3 3071, 2998, 1608, 1586, 1556, 1512, 1468, 1432, 1267, 1131, 1102, 1073, 1021, 952, 897 ; HRMS (ESI TOF) calculated for C 7 H 5 N 3 NaO (M + Na) + 170.0325, found 170.0330 3,4-oxadiazole (4db V245) . This material was obtained from 4-nitrobenzohydrazide (1d) (181 mg, 1.00 mmol) and nitromethane (6b) (581 mL, 610 mg, 10.0 mmol). The reaction was carried out at 95-105 C, and the titled compound was isolated as a yellow solid, mp 152-153 C (EtOAc), R f 0.32 (EtOAc/petroleum ether, 1 : 2). Yield 165 mg (0.86 mmol, 86% 3222, 3148, 3068, 1769, 1728, 1626, 1586, 1549, 1490, 1406, 1303, 1256, 1157, 1095, 1058, 952 8, 160.9, 153.8, 128.7, 116.2, 114.0; IR (KBr, lm, cm À1 ) 3147, 3027, 1615 , 1597 , 1498 , 1384 , 1285 , 1245 , 1179 , 1128 , 1065 6, 134.2, 132.1, 131.4, 127.8, 121.4; IR (KBr, lm, cm À1 ) 3314, 3204, 3093, 3027, 1659 , 1633 , 1593 , 1512 , 1457 , 1377 , 1307 , 1252 , 1106 , 1058 4, 165.3, 134.0, 131.8, 129.12, 129.08, 129.0, 127.7, 127.0, 124.0, 32.1; IR (KBr, lm, cm À1 ) 3075, 2928 , 2858 , 1567 , 1553 , 1490 , 1454 , 1424 , 1256 , 1095 , 1065 , 1010 4, 164.9, 133.7, 132.4, 131.9, 130.3, 129.3, 129.2, 127.0, 123.8, 31.4 6, 156.6, 154.6, 133.0, 129.4, 127.8, 122.9, 63.7, 14.3; IR (KBr, lm, cm À1 ) 3078, 2994 , 2941 , 1748 , 1625 , 1546 , 1478 , 1452 , 1377 , 1242 , 1190 , 1163 , 1070 , 1017 5, 157.0, 154.5, 134.9, 133.5, 132.2, 127.9, 124.4, 122.2, 63.8, 14.2; IR (KBr, lm, cm À1 ) 2985, 1748, 1598, 1535, 1441, 1377, 1298, 1253, 1186, 1167, 1100, 1028, 841, 770, 732 2, 158.4, 155.1, 154.2, 135.1, 127.4, 120.4, 118.0, 107.2, 63.9, 14.2; IR (KBr, lm, cm À1 ) 3245, 2986 , 1748 , 1625 , 1542 , 1493 , 1377 , 1313 , 1242 , 1186 , 1163 , 1058 , 1021 ; HRMS (ESI TOF) calculated for C 11 H 10 N 2 NaO 4 (M + Na) + 257.0533, found 257.0532 (0.5 ppm).
2-Methyl-5-(4-nitrophenyl)-1,3,4-oxadiazole (4da V233
(3.1 ppm). 2-(4-Nitrophenyl)-1,
